| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 22.496 | 47.447 | 60.061 | 72.580 | 81.632 | 98.299 | 101.557 | 128.481 | 157.349 |
| Total Income - EUR | - | 22.496 | 47.447 | 60.062 | 72.582 | 84.734 | 98.304 | 101.560 | 128.525 | 157.572 |
| Total Expenses - EUR | - | 10.855 | 21.679 | 24.003 | 23.810 | 31.394 | 29.241 | 32.360 | 30.173 | 34.994 |
| Gross Profit/Loss - EUR | - | 11.641 | 25.768 | 36.059 | 48.772 | 53.340 | 69.062 | 69.200 | 98.352 | 122.578 |
| Net Profit/Loss - EUR | - | 11.430 | 25.294 | 35.458 | 48.046 | 52.543 | 68.197 | 68.265 | 97.259 | 107.115 |
| Employees | - | 3 | 3 | 0 | 2 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Solran Medical Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | 13.008 | 27.028 | 38.460 | 51.366 | 59.346 | 123.508 | 72.942 | 165.495 | 119.030 |
| Inventories | - | 0 | 29 | 29 | 28 | 28 | 27 | 27 | 90 | 0 |
| Receivables | - | 0 | 0 | 9.636 | 25.232 | 27.246 | 87.538 | 47.670 | 133.448 | 92.743 |
| Cash | - | 13.008 | 26.999 | 28.795 | 26.105 | 32.072 | 35.943 | 25.244 | 31.957 | 26.287 |
| Shareholders Funds | - | 53 | 44 | 35.501 | 48.088 | 52.584 | 119.615 | 68.306 | 165.358 | 107.155 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 12.955 | 26.984 | 2.958 | 3.277 | 6.762 | 3.893 | 4.636 | 137 | 11.874 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Solran Medical Srl